Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Implementing Jess’s rule in England’s primary care

Jess Brady died at the age of 27 in December 2020 after 20 appointments with her general practice […]

November 20, 2025 Uncategorized

Gobivaz approved across Europe as first Simponi biosimilar

Gobivaz approved across Europe as first Simponi biosimilar
p p Read More

Alvotech and Advanz Pharma secure EC authorisation for treatment of immune-mediated diseases

November 20, 2025 News

Poolbeg granted European patent for POLB 001

Poolbeg granted European patent for POLB 001
p p Read More

New patent strengthens IP position for treatment of influenza side effects

November 20, 2025 News

Scientists reawaken exhausted T cells to supercharge cancer immunity

Researchers discovered a way to keep T cells from wearing out during the fight against cancer, and the […]

November 20, 2025 Uncategorized

Revealed: Thousands of NHS doctors are trapped in insecure “gig economy” contracts

Locally employed doctors (LEDs) are being “exploited” by NHS trusts using insecure contracts that deny them training, progression, […]

November 20, 2025 UK, Investigation

“Alarming” rise in HIV in women: MPs call for urgent expansion of testing

Ministers must expand HIV testing to settings such as general practices, abortion clinics, women’s health hubs, cervical screening […]

November 20, 2025 Uncategorized

Men’s health strategy for England is launched by ministers with backing from Premier League

The first men’s health strategy for England will focus on suicide prevention, alcohol misuse, and gambling problems to […]

November 20, 2025 Oncology, Psychiatry, General practice / family medicine, UK

TARA-002 shows strong early results in trial for paediatric lymphatic malformations

TARA-002 shows strong early results in trial for paediatric lymphatic malformations
p p Read More

Protara’s phase 2 STARBORN-1 study reports high response rates and no serious adverse events

November 20, 2025 News

Libtayo approved in EU as first adjuvant immunotherapy for high-risk CSCC

Libtayo approved in EU as first adjuvant immunotherapy for high-risk CSCC
p p Read More

New authorisation marks major milestone in earlier treatment of skin cancer

November 19, 2025 News

Inflammation turns bone marrow into a breeding ground for disease

Researchers discovered that chronic inflammation fundamentally remodels the bone marrow, allowing mutated stem cell clones to quietly gain […]

November 19, 2025 Uncategorized

Posts navigation

Posts pagination

« Previous 1 … 66 67 68 … 1,975 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy